Ετικέτες

Σάββατο 7 Απριλίου 2018

Scholar : ΜΕΝΙΕΡΕ - νέα αποτελέσματα

[PDF] Лечение вестибулярного головокружения у полиморбидного пациента

ОВ Косивцова, СА Яворская, ТГ Фатеева - Неврология, нейропсихиатрия …, 2018
… Keywords: vertigo; treatment; vestibular suppressive therapy; benign paroxysmal vertigo;
Meniere's disease (syndrome); vestibular neuronitis; polymorbidity; vestibular rehabilitation …
Does evidence-based medicine exist in the treatment of Meniere's disease …
Google+ Facebook Twitter

Incidence and Treatment Outcomes of Post Traumatic BPPV in Traumatic Brain Injury Patients

GR Haripriya, P Mary, M Dominic, R Goyal… - Indian Journal of …, 2018
… Previous history of vertigo was ruled out (eg Degenerating disorders, thyroid disorders,
episodic ataxia, CNS tumors, previous history of migraine, otological causes, known cases
of Meniere's dis- ease). Central causes of vertigo were also excluded from the study …
Google+ Facebook Twitter

[PDF] A Rare Cause of Unilateral Tinnitus

NMSNA Ghani, NAN Othmana, A Mohamadb
… INTRODUCTION Tinnitus is not a disease per se but it is a symptom. It can be either
subjective or objective type and the underlying cause varies such as tumour, infection,
vascular abnormality or Meniere's disease. Foreign …
Google+ Facebook Twitter

抗めまい薬

船曳和雄 - medicina, 2018
… イソバイド イソソルビド 用法・用量と使い方のポイント(表 1) 浸透圧利尿薬である.
内リンパ圧の上昇が推定 されるMénière 病などが適応となる.ブーンという
Page 4. 85 Vol.55 No.4 2018 増刊号 文献 1)James AL, et al:Betahistine …
Google+ Facebook Twitter

MIRNA MIMETICS AND THEIR USE IN TREATING SENSORY CONDITIONS

AL Jackson, CM Dalby - US Patent App. 15/558,505, 2018
… one or more modified nucleotides. 61. The method of claim 60, wherein the ear
disorder is selected from the group consisting of hearing loss, tinnitus, Meniere's
disease, and ear infections. 62. An expression vector comprising …
Google+ Facebook Twitter

Boron-Containing Diacylhydrazines

SK Chellappan, RE Hormann, I Shulman - US Patent App. 15/354,239, 2018
The present disclosure provides boron-containing diacylhydrazines having Formula
I: <p><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001"
he="24.98mm" wi="52.32mm" file="US20180079759A1-20.
Google+ Facebook Twitter

HETEROCYCLIC COMPOUND

S Ikeda, T Koike, J Aida, M Fushimi, T Kusumoto… - US Patent App. 15/563,161, 2018
The present invention provides a compound having an MAGL inhibitory action,
which is expected to be useful as an agent for the prophylaxis or treatment
of neurodegenerative diseases (eg, Alzheimer's.
Google+ Facebook Twitter

 

Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.



Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου